{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:08:23Z","timestamp":1793660903298,"version":"4.5.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:00:00Z","timestamp":1720915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LTGY24H190002"],"award-info":[{"award-number":["LTGY24H190002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008856","name":"Department of Health of Zhejiang Province","doi-asserted-by":"publisher","award":["2024XY041"],"award-info":[{"award-number":["2024XY041"]}],"id":[{"id":"10.13039\/501100008856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.pupt.2024.102315","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T11:05:51Z","timestamp":1720955151000},"page":"102315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The efficacy and safety of inhaled antibiotics for pneumonia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"86","author":[{"given":"Zengzeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pupt.2024.102315_bib1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.idc.2017.05.006","article-title":"Inhaled antibiotics for ventilator-associated infections","volume":"31","author":"Palmer","year":"2017","journal-title":"Infect Dis Clin North Am."},{"issue":"22","key":"10.1016\/j.pupt.2024.102315_bib2","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1056\/NEJMoa2310307","article-title":"Inhaled amikacin to prevent ventilator-associated pneumonia","volume":"389","author":"Ehrmann","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.pupt.2024.102315_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.idnow.2022.05.003","article-title":"Inhaled antibiotics in critical care: State of the art and future perspectives","volume":"52","author":"Szychowiak","year":"2022","journal-title":"Infect Dis Now"},{"issue":"10","key":"10.1016\/j.pupt.2024.102315_bib4","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.201312-2161OC","article-title":"Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit","volume":"189","author":"Palmer","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.pupt.2024.102315_bib5","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4103\/0366-6999.205846","article-title":"Aerosolized amikacin as adjunctive therapy of ventilator-associated pneumonia caused by multidrug-resistant gram-negative bacteria: a single-center randomized controlled trial","volume":"130","author":"Liu","year":"2017","journal-title":"Chin Med J (Engl)."},{"issue":"10","key":"10.1016\/j.pupt.2024.102315_bib6","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.3390\/jcm12103577","article-title":"Efficacy and safety of dry powder antibiotics: a Narrative review","volume":"12","author":"de la Rosa-Carrillo","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pupt.2024.102315_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2014.10.009","article-title":"Clinical applications of pulmonary delivery of antibiotics","volume":"85","author":"Flume","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.pupt.2024.102315_bib8","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1469-0691.2009.03040.x","article-title":"Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study","volume":"16","author":"Korbila","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.pupt.2024.102315_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2334-11-317","article-title":"A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa","volume":"11","author":"Naesens","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.pupt.2024.102315_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/QCO.0000000000000720","article-title":"On behalf of the European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia (ENAVAP). Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials","volume":"34","author":"Monsel","year":"2021","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.pupt.2024.102315_bib11","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dkq360","article-title":"Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria","volume":"65","author":"Rattanaumpawan","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.pupt.2024.102315_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.pupt.2024.102315_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"5","key":"10.1016\/j.pupt.2024.102315_bib14","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.pupt.2024.102315_bib15","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/CCM.0b013e31817c0f9e","article-title":"Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit","volume":"36","author":"Palmer","year":"2008","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.pupt.2024.102315_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1164\/rccm.201011-1894OC","article-title":"Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa","volume":"184","author":"Lu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.pupt.2024.102315_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-016-0127-7","article-title":"Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial","volume":"6","author":"Abdellatif","year":"2016","journal-title":"Ann. Intensive Care"},{"issue":"6","key":"10.1016\/j.pupt.2024.102315_bib18","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.chest.2016.11.026","article-title":"A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of gram-negative ventilator-associated pneumonia: IASIS trial","volume":"151","author":"Kollef","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.pupt.2024.102315_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/sja.SJA_148_17","article-title":"Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia","volume":"12","author":"Ammar","year":"2018","journal-title":"Saudi J. Anaesth."},{"issue":"1","key":"10.1016\/j.pupt.2024.102315_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/CCM.0000000000002695","article-title":"Nebulized versus IV amikacin as adjunctive antibiotic for hospital and ventilator-acquired pneumonia postcardiac surgeries: a randomized controlled trial","volume":"46","author":"Hassan","year":"2018","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.pupt.2024.102315_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1473-3099(19)30574-2","article-title":"Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial","volume":"20","author":"Niederman","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.pupt.2024.102315_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.accpm.2023.101249","article-title":"A prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled Tobramycin in patients with ventilator-associated pneumonia (iToVAP)","volume":"42","author":"Angermair","year":"2023","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"11","key":"10.1016\/j.pupt.2024.102315_bib23","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/657242","article-title":"Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study","volume":"51","author":"Kofteridis","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.pupt.2024.102315_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.medin.2011.01.013","article-title":"Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients","volume":"35","author":"P\u00e9rez-Pedrero","year":"2011","journal-title":"Med. Intensiva"},{"issue":"6","key":"10.1016\/j.pupt.2024.102315_bib25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s10156-012-0430-7","article-title":"Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?","volume":"18","author":"Kalin","year":"2012","journal-title":"J. Infect. Chemother."},{"issue":"1","key":"10.1016\/j.pupt.2024.102315_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2253-13-45","article-title":"Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study","volume":"13","author":"Doshi","year":"2013","journal-title":"BMC Anesthesiol."},{"issue":"6","key":"10.1016\/j.pupt.2024.102315_bib27","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1378\/chest.13-1018","article-title":"Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria","volume":"144","author":"Tumbarello","year":"2013","journal-title":"Chest"},{"issue":"Suppl. 1","key":"10.1016\/j.pupt.2024.102315_bib28","first-page":"29","article-title":"Inhalation plus intravenous colistin versus intravenous colistin alone for treatment of ventilator associated pneumonia","volume":"9","author":"Zah Bogovict","year":"2014","journal-title":"Signa Vitae: journal for intesive care and emergency medicine"},{"issue":"11","key":"10.1016\/j.pupt.2024.102315_bib29","first-page":"1319","article-title":"Clinical value of amikacin in treatment of Acinetobacter baumannii ventilator associated pneumonia","volume":"27","author":"Zhu","year":"2015","journal-title":"Chin. J. Microecol."},{"key":"10.1016\/j.pupt.2024.102315_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcrc.2017.04.004","article-title":"Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii","volume":"40","author":"Jang","year":"2017","journal-title":"J. Crit. Care"},{"issue":"3","key":"10.1016\/j.pupt.2024.102315_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.21037\/jtd.2017.02.61","article-title":"Efficacy of nebulized colistin-based therapy without concurrent intravenous colistin for ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii","volume":"9","author":"Kim","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.pupt.2024.102315_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/1753466619885529","article-title":"Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria","volume":"13","author":"Choe","year":"2019","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"1","key":"10.1016\/j.pupt.2024.102315_bib33","first-page":"1","article-title":"A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)","volume":"12","author":"El","year":"2020","journal-title":"Ain-Shams Journal of Anesthesiology"},{"issue":"1","key":"10.1016\/j.pupt.2024.102315_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.32429\/jkshp.2020.37.1.001","article-title":"Comparative evaluation of intravenous vs. Nebulized colistin treatment of pneumonia due to multidrug-resistant acinetobacter baumannii & Pseudomonas aeruginosa","volume":"37","author":"Ahn","year":"2020","journal-title":"Journal of Korean Society of Health-System Pharmacists."},{"key":"10.1016\/j.pupt.2024.102315_bib35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijid.2021.06.007","article-title":"Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: a retrospective cohort study","volume":"108","author":"Almangour","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.pupt.2024.102315_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2478\/jccm-2020-0044","article-title":"The susceptibility of MDR-K. Pneumoniae to polymyxin B plus its nebulised form versus polymyxin B alone in critically ill south asian patients","volume":"7","author":"Hasan","year":"2021","journal-title":"J Crit Care Med (Targu Mures)"},{"issue":"4","key":"10.1016\/j.pupt.2024.102315_bib37","first-page":"416","article-title":"Clinical study on intravenous combined with aerosol inhalation of polymyxin B for the treatment of pneumonia caused by multidrug-resistant Gram-negative bacteria","volume":"33","author":"Zhou","year":"2021"},{"issue":"1","key":"10.1016\/j.pupt.2024.102315_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13613-022-01033-5","article-title":"Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case-control study","volume":"12","author":"Liu","year":"2022","journal-title":"Ann. Intensive Care"},{"issue":"2","key":"10.1016\/j.pupt.2024.102315_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.pupt.2024.102315_bib40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jcrc.2017.09.019","article-title":"Effect of antibiotics administered via the respiratory tract in the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"43","author":"P\u00f3voa","year":"2018","journal-title":"J. Crit. Care"},{"issue":"2","key":"10.1016\/j.pupt.2024.102315_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QCO.0000000000000525","article-title":"Why have trials of inhaled antibiotics for ventilator-associated infections failed?","volume":"32","author":"Palmer","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.pupt.2024.102315_bib42","first-page":"855","article-title":"Lancet Respir Med. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"Laska","year":"2019"},{"issue":"3","key":"10.1016\/j.pupt.2024.102315_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02319-16","article-title":"Nephrotoxicity of polymyxins: is there any difference between colistimethate and polymyxin B?","volume":"61","author":"Zavascki","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.pupt.2024.102315_bib44","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s12325-023-02436-x","article-title":"Aminoglycoside-related nephrotoxicity and ototoxicity in clinical practice: a review of pathophysiological mechanism and treatment options","volume":"40","author":"Le","year":"2023","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.pupt.2024.102315_bib45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1183\/09031936.00018414","article-title":"Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review","volume":"44","author":"Brodt","year":"2014","journal-title":"Eur. Respir. J."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553924000312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553924000312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:22:46Z","timestamp":1725754966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553924000312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"alternative-id":["S1094553924000312"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2024.102315","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of inhaled antibiotics for pneumonia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2024.102315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102315"}}